The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Contract Development and Manufacturing Market Research Report 2025
Synopsis
The global Pharmaceutical Contract Development and Manufacturing market was valued at US$ 121370 million in 2023 and is anticipated to reach US$ 188680 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Development and Manufacturing.
Report Scope
The Pharmaceutical Contract Development and Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Development and Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Development and Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Catalent, Inc.
Lonza Group Ltd
Recipharm AB
Vetter Pharma International GMBH
FAMAR Health Care Services
AbbVie Inc.
Aenova Group
Consort Medical plc
Almac Group
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
Segment by Type
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Segment by Application
Big Pharma
Small Pharma
Generic Pharma
CRO
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Development and Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pharmaceutical Contract Development and Manufacturing market was valued at US$ 121370 million in 2023 and is anticipated to reach US$ 188680 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Development and Manufacturing.
Report Scope
The Pharmaceutical Contract Development and Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Development and Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Development and Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Catalent, Inc.
Lonza Group Ltd
Recipharm AB
Vetter Pharma International GMBH
FAMAR Health Care Services
AbbVie Inc.
Aenova Group
Consort Medical plc
Almac Group
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
Segment by Type
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Segment by Application
Big Pharma
Small Pharma
Generic Pharma
CRO
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Development and Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pharmaceutical Manufacturing Services
1.2.3 Biologics Manufacturing Services
1.2.4 Drug Development Services
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Development and Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Big Pharma
1.3.3 Small Pharma
1.3.4 Generic Pharma
1.3.5 CRO
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Development and Manufacturing Market Perspective (2019-2030)
2.2 Pharmaceutical Contract Development and Manufacturing Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Contract Development and Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Contract Development and Manufacturing Market Dynamics
2.3.1 Pharmaceutical Contract Development and Manufacturing Industry Trends
2.3.2 Pharmaceutical Contract Development and Manufacturing Market Drivers
2.3.3 Pharmaceutical Contract Development and Manufacturing Market Challenges
2.3.4 Pharmaceutical Contract Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
3.4 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Revenue in 2023
3.5 Pharmaceutical Contract Development and Manufacturing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Type
4.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Application
5.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)
6.2 North America Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)
7.2 Europe Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)
9.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Detail
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Catalent, Inc.
11.2.1 Catalent, Inc. Company Detail
11.2.2 Catalent, Inc. Business Overview
11.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.2.5 Catalent, Inc. Recent Development
11.3 Lonza Group Ltd
11.3.1 Lonza Group Ltd Company Detail
11.3.2 Lonza Group Ltd Business Overview
11.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Introduction
11.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.3.5 Lonza Group Ltd Recent Development
11.4 Recipharm AB
11.4.1 Recipharm AB Company Detail
11.4.2 Recipharm AB Business Overview
11.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Introduction
11.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.4.5 Recipharm AB Recent Development
11.5 Vetter Pharma International GMBH
11.5.1 Vetter Pharma International GMBH Company Detail
11.5.2 Vetter Pharma International GMBH Business Overview
11.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Introduction
11.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.5.5 Vetter Pharma International GMBH Recent Development
11.6 FAMAR Health Care Services
11.6.1 FAMAR Health Care Services Company Detail
11.6.2 FAMAR Health Care Services Business Overview
11.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Introduction
11.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.6.5 FAMAR Health Care Services Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Detail
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.7.5 AbbVie Inc. Recent Development
11.8 Aenova Group
11.8.1 Aenova Group Company Detail
11.8.2 Aenova Group Business Overview
11.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Introduction
11.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.8.5 Aenova Group Recent Development
11.9 Consort Medical plc
11.9.1 Consort Medical plc Company Detail
11.9.2 Consort Medical plc Business Overview
11.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Introduction
11.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.9.5 Consort Medical plc Recent Development
11.10 Almac Group
11.10.1 Almac Group Company Detail
11.10.2 Almac Group Business Overview
11.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Introduction
11.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.10.5 Almac Group Recent Development
11.11 Siegfried Holding AG
11.11.1 Siegfried Holding AG Company Detail
11.11.2 Siegfried Holding AG Business Overview
11.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Introduction
11.11.4 Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.11.5 Siegfried Holding AG Recent Development
11.12 Boehringer Ingelheim International GmbH
11.12.1 Boehringer Ingelheim International GmbH Company Detail
11.12.2 Boehringer Ingelheim International GmbH Business Overview
11.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Introduction
11.12.4 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.12.5 Boehringer Ingelheim International GmbH Recent Development
11.13 Evonik Industries AG
11.13.1 Evonik Industries AG Company Detail
11.13.2 Evonik Industries AG Business Overview
11.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Introduction
11.13.4 Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
11.13.5 Evonik Industries AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Pharmaceutical Manufacturing Services
Table 3. Key Players of Biologics Manufacturing Services
Table 4. Key Players of Drug Development Services
Table 5. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pharmaceutical Contract Development and Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pharmaceutical Contract Development and Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region (2019-2024)
Table 9. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region (2025-2030)
Table 11. Pharmaceutical Contract Development and Manufacturing Market Trends
Table 12. Pharmaceutical Contract Development and Manufacturing Market Drivers
Table 13. Pharmaceutical Contract Development and Manufacturing Market Challenges
Table 14. Pharmaceutical Contract Development and Manufacturing Market Restraints
Table 15. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players (2019-2024)
Table 17. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2023)
Table 18. Ranking of Global Top Pharmaceutical Contract Development and Manufacturing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
Table 22. Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2019-2024)
Table 26. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2025-2030)
Table 28. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2019-2024)
Table 30. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2025-2030)
Table 32. North America Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Thermo Fisher Scientific Inc. Company Detail
Table 48. Thermo Fisher Scientific Inc. Business Overview
Table 49. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product
Table 50. Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 51. Thermo Fisher Scientific Inc. Recent Development
Table 52. Catalent, Inc. Company Detail
Table 53. Catalent, Inc. Business Overview
Table 54. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product
Table 55. Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 56. Catalent, Inc. Recent Development
Table 57. Lonza Group Ltd Company Detail
Table 58. Lonza Group Ltd Business Overview
Table 59. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product
Table 60. Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 61. Lonza Group Ltd Recent Development
Table 62. Recipharm AB Company Detail
Table 63. Recipharm AB Business Overview
Table 64. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product
Table 65. Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 66. Recipharm AB Recent Development
Table 67. Vetter Pharma International GMBH Company Detail
Table 68. Vetter Pharma International GMBH Business Overview
Table 69. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product
Table 70. Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 71. Vetter Pharma International GMBH Recent Development
Table 72. FAMAR Health Care Services Company Detail
Table 73. FAMAR Health Care Services Business Overview
Table 74. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product
Table 75. FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 76. FAMAR Health Care Services Recent Development
Table 77. AbbVie Inc. Company Detail
Table 78. AbbVie Inc. Business Overview
Table 79. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product
Table 80. AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 81. AbbVie Inc. Recent Development
Table 82. Aenova Group Company Detail
Table 83. Aenova Group Business Overview
Table 84. Aenova Group Pharmaceutical Contract Development and Manufacturing Product
Table 85. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 86. Aenova Group Recent Development
Table 87. Consort Medical plc Company Detail
Table 88. Consort Medical plc Business Overview
Table 89. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product
Table 90. Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 91. Consort Medical plc Recent Development
Table 92. Almac Group Company Detail
Table 93. Almac Group Business Overview
Table 94. Almac Group Pharmaceutical Contract Development and Manufacturing Product
Table 95. Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 96. Almac Group Recent Development
Table 97. Siegfried Holding AG Company Detail
Table 98. Siegfried Holding AG Business Overview
Table 99. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product
Table 100. Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 101. Siegfried Holding AG Recent Development
Table 102. Boehringer Ingelheim International GmbH Company Detail
Table 103. Boehringer Ingelheim International GmbH Business Overview
Table 104. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product
Table 105. Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 106. Boehringer Ingelheim International GmbH Recent Development
Table 107. Evonik Industries AG Company Detail
Table 108. Evonik Industries AG Business Overview
Table 109. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product
Table 110. Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)
Table 111. Evonik Industries AG Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Contract Development and Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmaceutical Contract Development and Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. Pharmaceutical Manufacturing Services Features
Figure 4. Biologics Manufacturing Services Features
Figure 5. Drug Development Services Features
Figure 6. Global Pharmaceutical Contract Development and Manufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2023 VS 2030
Figure 8. Big Pharma Case Studies
Figure 9. Small Pharma Case Studies
Figure 10. Generic Pharma Case Studies
Figure 11. CRO Case Studies
Figure 12. Pharmaceutical Contract Development and Manufacturing Report Years Considered
Figure 13. Global Pharmaceutical Contract Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Pharmaceutical Contract Development and Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region: 2023 VS 2030
Figure 16. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players in 2023
Figure 17. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2023
Figure 19. North America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2019-2030)
Figure 21. United States Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Country (2019-2030)
Figure 25. Germany Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Share by Region (2019-2030)
Figure 33. China Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2019-2030)
Figure 41. Mexico Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Share by Country (2019-2030)
Figure 45. Turkey Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 48. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 49. Lonza Group Ltd Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 50. Recipharm AB Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 51. Vetter Pharma International GMBH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 52. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 53. AbbVie Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 54. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 55. Consort Medical plc Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 56. Almac Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 57. Siegfried Holding AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 58. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 59. Evonik Industries AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
